Chiesi is seeking research proposals for Respiratory and Neonatology therapeutic targets from academic medical centers, universities, and research institutions in North America and Europe.
Chiesi is reaching out to researchers and physician-scientists interested in collaborating with a global pharma company with a strong track record of translational R&D in respiratory and neonatology care.
Their objective is to award funds to validate early-stage projects with clear therapeutic potential. Successful applicants will be funded through sponsored research, with up to $280K available per project for a minimum of one year and a maximum of two years’ duration. This should enable researchers to generate relevant preclinical data or demonstrate preclinical proof of concept and help bring novel technologies to a mature enough state where they might be brought into the Chiesi pipeline and ultimately benefit patients.
Proposal Submission Process
The first step in the process is submission of a Pre-Proposal which should contain a brief, non-confidential 2-3 page overview of the target, mechanism (including evidence for link to disease), and the proposed therapeutic opportunity. A more detailed Full Proposal will be solicited by invitation only.
Pre-Proposal Deadline: April 5